UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 457

Sortiert nach

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Cancer discovery, 2016-02, Vol.6 (2), p.133-146

2016

Link zum Volltext

Verfügbarkeit prüfen

Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors

Cancer cell, 2019-11, Vol.36 (5), p.471-482

2019

Link zum Volltext

Verfügbarkeit prüfen

Fleischner Society Glossary: The Power of Standardization of Nomenclature for Thoracic Surgical Communications

Radiology, 2024-03, Vol.310 (3), p.e240410

Adusumilli, Prasad S

2024

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence

Clinical cancer research, 2014-11, Vol.20 (21), p.5384-5391

2014

Link zum Volltext

Verfügbarkeit prüfen

Commentary: Preoperative identification of spread through air spaces (STAS): An elusive biomarker

The Journal of thoracic and cardiovascular surgery, 2023-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors

Cancer cell, 2022-06, Vol.40 (6), p.569-574

2022

Link zum Volltext

Verfügbarkeit prüfen

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

The Journal of clinical investigation, 2016-08, Vol.126 (8), p.3130-3144

2016

Link zum Volltext

Verfügbarkeit prüfen

Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas

Journal of thoracic oncology, 2015-05, Vol.10 (5), p.806-814

2015

Link zum Volltext

Verfügbarkeit prüfen

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

Science translational medicine, 2014-11, Vol.6 (261), p.261ra151

2014

Link zum Volltext

Verfügbarkeit prüfen

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

CA: a cancer journal for clinicians, 2019-09, Vol.69 (5), p.402-429

2019

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

Nature communications, 2021-02, Vol.12 (1), p.729-729, Article 729

2021

Link zum Volltext

Verfügbarkeit prüfen

Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions

Chest, 2022-02, Vol.161 (2), p.572-582

2022

Link zum Volltext

Verfügbarkeit prüfen

CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapy

Oncoimmunology, 2017-02, Vol.6 (2), p.e1273302-e1273302

2017

Link zum Volltext

Verfügbarkeit prüfen

Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies

Journal of thoracic oncology, 2018-01, Vol.13 (1), p.16-26

2018

Link zum Volltext

Verfügbarkeit prüfen

Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer–Specific Death in Squamous Cell Carcinoma

Journal of thoracic oncology, 2017-02, Vol.12 (2), p.223-234

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity

Nature protocols, 2021-03, Vol.16 (3), p.1331-1342

2021

Link zum Volltext

Verfügbarkeit prüfen

Driving CARs on the uneven road of antigen heterogeneity in solid tumors

Current opinion in immunology, 2018-04, Vol.51, p.103-110

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller

JNCI : Journal of the National Cancer Institute, 2013-08, Vol.105 (16), p.1212-1220

2013

Link zum Volltext

Verfügbarkeit prüfen

Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival

PloS one, 2014-12, Vol.9 (12), p.e114900-e114900

2014

Link zum Volltext

Verfügbarkeit prüfen

Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival

Journal of clinical oncology, 2015-09, Vol.33 (26), p.2877-2884

2015

Link zum Volltext

Verfügbarkeit prüfen

Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2019-07, Vol.158 (1), p.269-276

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy

Annals of surgery, 2017-02, Vol.265 (2), p.431-437

2017

Link zum Volltext

Verfügbarkeit prüfen

Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma

Journal of thoracic oncology, 2019-03, Vol.14 (3), p.482-493

2019

Link zum Volltext

Verfügbarkeit prüfen

Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal disease

Lung cancer (Amsterdam, Netherlands), 2022-12, Vol.174, p.60-66

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 457

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(421)
Mit Volltextzugriff
(409)

Publikationsform

Sprache

Englisch
(453)
Japanisch
(70)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors

Fleischner Society Glossary: The Power of Standardization of Nomenclature for Thoracic Surgical Communications

Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence

Commentary: Preoperative identification of spread through air spaces (STAS): An elusive biomarker

Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions

CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapy

Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies

Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer–Specific Death in Squamous Cell Carcinoma

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity

Driving CARs on the uneven road of antigen heterogeneity in solid tumors

Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller

Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival

Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival

Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer

Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy

Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma

Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal disease

Suchergebnisse filtern